|
TBPH Theravance Biopharma Inc 1583107 |
| Balance Sheet |
|
Current Assets
|
$417,634,000.00 |
|
Assets
|
$472,313,000.00 |
|
Current Liabilities
|
$31,775,000.00 |
|
Equity
|
$290,594,000.00 |
|
Shares Out
|
51515000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$73,279,000.00 |
|
Investing Cash Flow
|
$52,593,000.00 |
| Market Analysis |
Market Cap
|
$868,027,750.00 |
|
Price
|
$16.86 |
|
BVPS
|
5.64 |
|
PB
|
2.99 |
|
EPS
|
-0.10 |
|
PE
|
8.00 |
|
PS
|
12.32 |
|
FCF
|
$73,237,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
1.15 |
|
|
2026-05-07 |
-0.10 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
1.08 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
0.07 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TBPH documents filed with the SEC.
TBPH Filings
Clear
